Researchers are calling for an urgent overhaul of diagnostic and treatment guidelines for infections in newborn babies, after ...
The new study, published in the journal Nature Microbiology, revealed in high-resolution images and biochemical experiments ...
New Scientist on MSN
Extraordinary pictures show what a common antibiotic does to E. coli
The way antibiotics called polymyxins pierce the armour of bacteria has been revealed in stunning detail by high-resolution microscopy, which could help develop new treatments for drug-resistant ...
Researchers have revealed how polymyxins, crucial last-resort antibiotics, break down bacterial armor by forcing cells to ...
A team led by UCL (University College London) and Imperial College London researchers has shown for the first time how ...
Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis, while sparing healthy microbes in the mouse ...
The antibiotic polymyxin can pierce the armor of active bacteria, but are ineffective when armor production is shut off in dormant bacteria.
LpxC inhibitors target a zinc-dependent deacetylase that catalyses the first committed step in lipid A biosynthesis, an essential process for the viability of Gram-negative bacteria. As lipid A forms ...
Short peptides can self-assemble into net-like structures that kill bacteria. Now, researchers have discovered how to control ...
In a recent study published in the journal Nature, researchers in the United States of America designed and discovered lolamicin, a selective antibiotic that targets the lipoprotein transport system ...
Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results